CAJ | 학술논문

目的：评价荧光素眼底血管造影(FFA)在糖尿病性黄斑水肿诊断和指导治疗方面的价值。方法：采用FFA对98例(196只眼)糖尿病患者进行筛查，对存在的黄斑水肿程度进行分级，并根据黄斑水肿程度指导治疗。随访1～6个月，观察患者视力、眼压、眼底改变及FFA表现。结果：经FFA检查筛查出67只眼(占34.18%)存在黄斑水肿，其中轻度糖尿病性黄斑水肿31只眼(占46.27%)，采用结膜下注射曲安奈德0.5 ml(20 mg)；中度糖尿病性黄斑水肿20只眼(占29.85%)，采用结膜下注射曲安奈德0.5 ml(20 mg)联合黄斑部激光光凝；重度糖尿病性黄斑水肿16只眼(占23.88%)，采用玻璃体腔注射曲安奈德0.1 ml(4 mg)联合黄斑部激光光凝。治疗后所有患者视力均有不同程度提高，黄斑水肿均有减轻。有5只眼出现眼压升高，经局部滴降眼压药后控制。结论：FFA对糖尿病性黄斑水肿的诊断、指导治疗及随访观察有着重要作用。
목적：평개형광소안저혈관조영(FFA)재당뇨병성황반수종진단화지도치료방면적개치。방법：채용FFA대98례(196지안)당뇨병환자진행사사，대존재적황반수종정도진행분급，병근거황반수종정도지도치료。수방1～6개월，관찰환자시력、안압、안저개변급FFA표현。결과：경FFA검사사사출67지안(점34.18%)존재황반수종，기중경도당뇨병성황반수종31지안(점46.27%)，채용결막하주사곡안내덕0.5 ml(20 mg)；중도당뇨병성황반수종20지안(점29.85%)，채용결막하주사곡안내덕0.5 ml(20 mg)연합황반부격광광응；중도당뇨병성황반수종16지안(점23.88%)，채용파리체강주사곡안내덕0.1 ml(4 mg)연합황반부격광광응。치료후소유환자시력균유불동정도제고，황반수종균유감경。유5지안출현안압승고，경국부적강안압약후공제。결론：FFA대당뇨병성황반수종적진단、지도치료급수방관찰유착중요작용。
Objective:To evaluate the effect of fundus fluorescein angiography(FFA) on diagnosis and treatment of diabetic macular edema(DME).Methods: The changes of images of FFA in 98 patients(196 eyes) diagnosed with diabetic retinopathy(DR) were observed and analyzed. The degree of macular edema of the patients was classified by FFA. The treatments were performed according to the degree of macular edema. During 1~6 months follow-up, the visual acuity, intraocular pressure, fundus and FFA were observed.Results: There are 67 eyes with DME in 196 eyes with DR(34.18%). 31 eyes(46.27%) with mild DME were treated with bulbar conjunctiva injection of 0.5ml(20mg) triamcinolone acetonide(TA); 20 eyes(29.85%) with moderate DME were treated with bulbar conjunctiva injection of 0.5ml(20mg) TA combined with laser for macula; 16 eyes with severe DME were treated with intravitreous injection of 0.1ml(4mg) TA combined with laser for macula. The visual acuity and the degree of macular edema of all the patients have been improved in varying degrees. Elevation of intraocular pressure occurred in 5 patients,but were controlled by eyedrops. Conclusion: FFA plays an important role in the diagnosis, guiding treatment and follow-up observation of DME.